Now let me search for a couple more specific items to ensure comprehensive and current coverage. I now have comprehensive, current evidence. Here is the synthesis:
The single most promising near-term path to field-deployable blight-resistant American chestnuts is recurrent genomic selection (RGS) within hybrid populations derived from American × Chinese chestnut crosses, as now being operationalized by The American Chestnut Foundation (TACF). This strategy is expected to produce a population of trees with sufficient disease resistance to survive in the wild within two breeding cycles. The landmark Westbrook et al. paper published in February 2026 in *Science* demonstrated that the complex genetic architecture of disease resistance means that recurrent selection is likely to be more effective than backcrossing. Critically, the study showed that hybrids with around 70% American chestnut ancestry have substantial blight resistance but also show resistance to another problematic disease called root rot. According to Westbrook, "with genome-enabled breeding, we expect the next generation of trees to have twice the average blight resistance of our current population, with an average of 75 percent American chestnut ancestry," and "the next generation of trees is expected to start producing large quantities of seed for forest restoration in the next decade." TACF is now running four parallel breeding tracks within the RGS program: three using backcross hybrid trees to maximize blight resistance, balance blight and Phytophthora root rot (PRR) resistance simultaneously, or maximize PRR resistance — all while maintaining a minimum of 70% American chestnut ancestry — plus a fourth non-hybrid track maximizing blight resistance among offspring of large surviving American chestnuts. This multi-track RGS approach is the most realistic path to operationally plantable trees because it avoids the regulatory quagmire surrounding transgenic lines while leveraging validated genomic prediction models.
The most significant recent scientific development is the Westbrook et al. (2026) *Science* paper itself, which represents a paradigm shift for the restoration program. Researchers analyzed thousands of chestnut trees that had already gone through years of breeding and field testing by TACF, and by sequencing their genomes and comparing genetic patterns with real-world disease outcomes, showed that resistance can be predicted using DNA data alone. This eliminates the years-long wait for phenotypic inoculation results, dramatically compressing generation intervals. Equally important, the team's comparative transcriptomics and metabolomics identified a specific molecular target: Chinese chestnut had elevated concentrations of triterpene sterols, including a 22-fold increase in lupeol, and testing showed that lupeol completely suppressed blight fungal growth in vitro, whereas erythrodiol partially inhibited it. The authors concluded that "gene editing or hybrid breeding strategies to enhance triterpene sterol biosynthesis, particularly lupeol production, could be a promising strategy to improve blight resistance in C. dentata." This identification of lupeol as a candidate target provides actionable molecular handles for future gene-editing interventions, complementing the breeding approach with a precision biotechnology avenue. As a *Nature Plants* commentary noted, "although none of these approaches offers a silver bullet, this study reveals that substantial resistance gains are possible, particularly through recurrent selection within hybrid populations."
The biggest remaining bottlenecks are both institutional and scientific. On the transgenic front, the Darling line — once heralded as a leading restoration tool — has been severely set back. In 2023, TACF decided to withdraw support of the D58 transgenic chestnut petitions after observational data from multiple orchard locations indicated inconsistent blight resistance, a negative impact on growth, and decreased survival rates. A labeling error at SUNY-ESF resulted in confusion between Darling 54 and Darling 58, with the error possibly occurring as early as 2016 but not discovered until 2023, meaning the regulatory petitions were filed as D58 when they should have been identified as D54. In D54, the OxO gene was inserted into a coding region, causing a deletion of 1,069 base pairs in a salinity tolerance gene called SAL1, and the homozygous state has been shown to be largely lethal. The transgenic chestnuts remain under federal regulatory review by the EPA, USDA-APHIS, and FDA, with timing unpredictable for any of the agencies and the EPA potentially involving a multi-phased approval process. This represents the first time a transgenic forest tree has been considered for restoration use, creating an unprecedented regulatory situation. Meanwhile, TACF and its partners are developing next-generation "DarWin" lines using a wound-inducible promoter: expressing OxO with inducible promoters that confine expression to only blight-infected tissue has the potential to reduce the growth and survival penalties observed with constitutive promoters. But these trees are at the T0 or T1 stage, meaning they are years away from field deployment. The dual challenge of Phytophthora root rot, which is widespread in soils south of 40° North latitude and occupies the southern half of American chestnut's former range, further complicates restoration: simulations showed that root rot greatly reduced chestnut biomass on the landscape even at the highest currently observed resistance levels, and warming climate enhanced pathogen virulence.
New funding would have the highest impact-per-dollar if directed at three specific leverage points. First and foremost, investment in TACF's RGS infrastructure — high-throughput genotyping, accelerated breeding using high-light growth chambers that produce pollen in less than two years compared to 5–7 years in the field, shortening breeding cycles and speeding up tree generations — would directly compress the timeline to seed-production orchards. As Westbrook notes, "recurrent genomic selection lets us predict which trees will perform best before they reach maturity," and "it's a method proven in agriculture and forestry, and applying it to conservation allows restoration to operate at a scale and efficiency we've never had before." Second, research indicates that root rot resistance must be enhanced through breeding and biotechnology, and that restoration efforts will be more successful if targeted to latitudes, elevations, and site conditions where root rot is not expected to be present well into the future; funding integrated PRR resistance screening across TACF's regionalized breeding zones would prevent a situation where blight-resistant trees fail upon deployment due to a second pathogen. Third, advancing gene-editing tools for lupeol pathway enhancement and developing new OxO lines with inducible promoters across genetically diverse regional founders — work underway at the University of Georgia and SUNY-ESF, where researchers are collaborating to transform up to three additional American chestnut genotypes from Georgia, Virginia, and Pennsylvania with the OxO gene to reduce the potential for deleterious inbreeding and founder effects — would build the biotechnological pipeline needed to complement genomic selection in subsequent breeding cycles. These investments are synergistic: genomic selection accelerates near-term gains, PRR screening prevents geographic bottlenecks, and biotechnology extends the ceiling of achievable resistance.